Clinical Trial: A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adults
Study Status: NOT_YET_RECRUITING
Recruit Status: NOT_YET_RECRUITING
Condition: Pneumococcal Disease
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2, Randomized, Double-Blind Trial of the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 18 Years of Age and Older
Brief Summary:
The purpose of this study is to learn about the safety and immune effects of a pneumococcal vaccine in adults.This vaccine can possibly provide protection against further pneumococcal disease.This study will happen in in 2 stages: Stage 1 is seeking participants who are between 18 years to 49 years of age.The participants will receive 1 of 2 pneumococcal vaccine candidates (different formulations) or 20vPnC (Prevnar 20) as a single shot given into the upper arm muscle.Stage 2 will begin after participants have…
Read more